Perfromance Wealth Partners, LLC Sarepta Therapeutics, Inc. Transaction History
Perfromance Wealth Partners, LLC
- $3.09 Billion
- Q4 2024
A detailed history of Perfromance Wealth Partners, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Perfromance Wealth Partners, LLC holds 1,726 shares of SRPT stock, worth $187,115. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,726
Previous 2,926
41.01%
Holding current value
$187,115
Previous $365,000
42.74%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding SRPT
# of Institutions
536Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.12 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$985 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$943 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$469 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$441 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.49B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...